全文获取类型
收费全文 | 46573篇 |
免费 | 4955篇 |
国内免费 | 771篇 |
专业分类
耳鼻咽喉 | 715篇 |
儿科学 | 1175篇 |
妇产科学 | 692篇 |
基础医学 | 2342篇 |
口腔科学 | 1245篇 |
临床医学 | 8950篇 |
内科学 | 7327篇 |
皮肤病学 | 918篇 |
神经病学 | 3875篇 |
特种医学 | 506篇 |
外国民族医学 | 3篇 |
外科学 | 4853篇 |
综合类 | 4482篇 |
现状与发展 | 1篇 |
一般理论 | 6篇 |
预防医学 | 6866篇 |
眼科学 | 433篇 |
药学 | 2656篇 |
84篇 | |
中国医学 | 1350篇 |
肿瘤学 | 3820篇 |
出版年
2024年 | 161篇 |
2023年 | 1229篇 |
2022年 | 1957篇 |
2021年 | 2690篇 |
2020年 | 2857篇 |
2019年 | 2711篇 |
2018年 | 2431篇 |
2017年 | 2474篇 |
2016年 | 2310篇 |
2015年 | 2098篇 |
2014年 | 3651篇 |
2013年 | 4168篇 |
2012年 | 2652篇 |
2011年 | 2756篇 |
2010年 | 2005篇 |
2009年 | 2225篇 |
2008年 | 2246篇 |
2007年 | 2140篇 |
2006年 | 1771篇 |
2005年 | 1494篇 |
2004年 | 1206篇 |
2003年 | 1006篇 |
2002年 | 702篇 |
2001年 | 634篇 |
2000年 | 518篇 |
1999年 | 346篇 |
1998年 | 292篇 |
1997年 | 254篇 |
1996年 | 231篇 |
1995年 | 188篇 |
1994年 | 140篇 |
1993年 | 133篇 |
1992年 | 127篇 |
1991年 | 75篇 |
1990年 | 71篇 |
1989年 | 64篇 |
1988年 | 56篇 |
1987年 | 40篇 |
1986年 | 35篇 |
1985年 | 35篇 |
1984年 | 23篇 |
1983年 | 16篇 |
1982年 | 15篇 |
1981年 | 19篇 |
1980年 | 11篇 |
1979年 | 5篇 |
1978年 | 3篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1975年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
111.
子宫切除术对生存质量的影响 总被引:10,自引:0,他引:10
目的:研究子宫切除术对生存质量的影响。方法:对108例因良性疾病而行腹式子宫切除术者进行前瞻性队列研究,术前及术后3,6,12个月进行调查问卷,观察症状、泌尿及胃肠功能、性功能、心理状况、社会生活状态的变化。结果:子宫切除术后3个月症状、压抑、焦虑程度减轻,社会生活状态显著提高,泌尿及胃肠功能、性功能无改变,这些改善持续至术后12个月。结论:子宫切除术可有效缓解妇科良性疾病所产生的症状,症状的缓解有利于改善生存质量。大多数因妇科良性疾病而行腹式子宫切除术的妇女,在术后1年,生存质量提高。 相似文献
112.
I. Wiklund F. Waagstein K. Swedberg Å. Hjalmarsson 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1996,10(3):361-368
Summary Quality of life in heart failure patients is receiving increased attention as a reflection of a treatment's potential secondary
benefit of general well-being and daily functioning. The Metoprolol in Dilated Cardiomyopathy (MDC) trial was conducted as
a large, multicenter trial to establish the effects of metoprolol on mortality and need for heart transplantation in patients
with symptomatic idiopathic cardiomyopathy. It was found that metoprolol was well tolerated, improved symptoms and cardiac
function, and prevented clinical deterioration in patients with symptomatic idiopathic dilated cardiomyopathy. Quality of
life was evaluated as a secondary endpoint in 345 out of 383 randomized patients using a disease-specific questionnaire, the
Quality of Life in Heart Failure Questionnaire, depicting physical activity, somatic symptoms, emotions, and life satisfaction.
In a comparison of patients treated with metoprolol or placebo, patients treated with metoprolol noted a significantly more
favorable response than those treated with placebo in terms of the overall treatment evaluation (p<0.05). Additionally, an
analysis of the changes from baseline to 18 months, using 95% confidence intervals, revealed that patients treated with metoprolol
showed a significant improvement from baseline to 18 months in life satisfaction, physical activity, and the total score,
while patients treated with placebo did not change at all. The improvement in quality of life was supported by the correlations
with improvement in traditional clinical parameters. 相似文献
113.
In the last few years, survival of patients infected with human immunodeficiency virus (HIV) has been improved because of a decreased incidence of some opportunistic complications attributable to prophylactic treatments and antiretroviral drugs. The impact of these agents should also be reflected in the quality of life (QoL) of patients. We have reviewed this topic with an emphasis on different types of measurements such as Q-TWIST, MOS and the Spitzer score which seem to be most appropriate for this patient population. We do not think that a special type of assessment should be designed for HIV-infected persons. It would be less time-consuming to improve already existing validated scores focusing on HIV infection. QoL in intravenous drug users with HIV should be evaluated more often. 相似文献
114.
Life satisfaction in patients with chest pain subsequently diagnosed as coronary heart disease – connection through depressive symptoms? 总被引:3,自引:0,他引:3
Valkamo M. Koivumaa-Honkanen H.-T. Hintikka J. Niskanen L. Honkalampi K. Viinamäki H. 《Quality of life research》2003,12(8):1099-1105
The aim of this study was to investigate factors associated with life dissatisfaction in symptomatic patients (n = 144) with chest pain subsequently diagnosed as coronary heart disease (CHD) by coronary angiography. Life dissatisfaction was assessed with a four-item life satisfaction scale (LS), depression with the 21-item Beck Depression Inventory (BDI) and other psychiatric symptoms with the symptom check list (SCL). DSM-III-R Axis I and Axis II psychiatric diagnoses were performed by means of the Structured Clinical Interview. All assessments took place one day before angiography. Twenty-four per cent of CHD patients were dissatisfied with their lives. Life dissatisfaction was associated with being unmarried. Dissatisfied patients had Axis I mental disorders and Axis II personality disorders more frequently than others. Psychiatric and depressive symptoms according to the SCL and BDI, respectively, were also higher among dissatisfied patients. In multiple logistic regression analyses, mental disorders were related to life dissatisfaction when age, sex, employment status, New York Heart Association class, duration of chest pain symptoms and work load were controlled in the model. Married subjects had a lower probability of being dissatisfied with their lives than other subjects (Odds Ratio, OR: 0.23). When BDI scores were included in the model, the only factor independently associated with life dissatisfaction was the severity of depressive symptoms (OR: 1.81). To conclude, life dissatisfaction is not primarily determined by the severity of CHD but by the existence of depressive symptoms. 相似文献
115.
M. Sibille N. Deigat V. Olagnier D. Vital Durand R. Levrat 《European journal of clinical pharmacology》1992,42(4):389-393
Summary All the clinical, laboratory and electrocardiographic adverse events detected during 24 Phase I studies in the same unit over a 5 y period are reported here. 430 healthy male volunteers were involved, corresponding to 5488 days of follow-up.The overall incidence of adverse events was 13.5%, with a significant difference between active drug (15.3%) and placebo (7.4%) treatments. There were 69 distinct types of adverse events. Headache was the most frequent symptom (2%). There were severe adverse events in 20 cases (0.36%), with an incidence of 20/430 per subject (4.6%). There were no deaths or life-threatening events.Although the main objective of Phase I studies is to determine the maximum dose tolerated, cause-effect relationships with adverse events are hard to establish, because of the frequency of adverse events with placebo, and because of the limited number of subjects included such studies. 相似文献
116.
117.
Quality of life in adult survivors of lung,colon and prostate cancer 总被引:22,自引:0,他引:22
C. A. C. Schag P. A. Ganz D. S. Wing M. -S. Sim J. J. Lee 《Quality of life research》1994,3(2):127-141
In a cross-sectional study design, a disease free sample of 57 lung, 117 colon, and 104 prostate cancer survivors who represented short, intermediate and long-term survivors completed a detailed assessment of quality of life (QOL) and rehabilitation needs using the CAncer Rehabilitation Evaluation System (CARES). Demographic and medical data, social support, and a global QOL rating were also assessed. Lung cancer patients showed no differences in QOL with respect to their period of survival. QOL improved for survivors of colon cancer as they lived for longer periods, but declined with time for survivors of prostate cancer. The best predictor of QOL for all groups was KPS, although other variables such as type of hospital, gender, and work status were predictive for survivors of colon cancer. For survivors of prostate cancer comorbidity with other medical illnesses, time since diagnosis and comorbidity due to psychiatric difficulties were predictive of QOL. All groups had significant rehabilitation problems in the domains of physical, psychosocial, sexual, medical interaction, and marital relationships. Lung cancer survivors had more problems than the other cancer survivors. We conclude that patients who survive cancer do not return to a state of normal health. They demonstrate a variety of difficulties with which they must cope as they continue to survive. Greater efforts need to be made early in diagnosis and treatment to understand rehabilitation problems and target interventions in the hope of reducing later sequelae.Currently in private practice, Glendale, CaliforniaC. A. C. Schag was supported in part by Veterans Administration Health Research and Development Grant 83-002 and in part by Cares Consultants, 2210 Wilshire Blvd., Suite 359, Santa Monica, CA 90403.Address requests for Information about CARES to: CARES Consultants, 2210 Wilshire Blvd., Suite 359, Santa Monica, CA 90403, USA. Tel: (+1) 310-450-7410; Fax: (+1) 310-399-0016 相似文献
118.
消化道恶性肿瘤确诊初期患者社会支持与生命质量的调查 总被引:6,自引:1,他引:5
目的 调查消化道恶性肿瘤确诊初期的患者半年中的社会支持和生命质量变化。方法 采用社会支持评定量表和CARES-SF对146名患者的社会支持和生命质量进行为期半年的追踪调查。结果 消化道恶性肿瘤确诊初期患者的生命质量为中等,其中婚姻关系维度、性关系维度得分半年后下降。患者所获得的社会支持最多的是情感支持,其次是实际支持,信息支持为第三位。情感支持大多来源于家庭成员,信息支持大多来源于医务人员。患者大多很少参与社交活动。在半年中情感支持、实际支持、信息支持的变化模式不一。诊断初期的患者不能有效地利用社会支持。结论 应对确诊初期患者加强咨询,以充分识别和利用社会资源。应持续评估患者的生命质量和社会支持,并制订干预方案,提高消化道恶性肿瘤确诊初期患者的社会支持程度,最终提高其生命质量。 相似文献
119.
120.
This study was designed to evaluate the reproducibility, validity and responsiveness of a health-related quality of life (HRQOL) battery that was assembled for the evaluation of antidepressant therapy. The Montgomery-Asberg Depression Rating Scale was used to measure severity of depression. The HRQOL battery contained measures of energy and fatigue, social behaviour, cognitive function, home and work role function, and general well-being (i.e., health perceptions, life satisfaction) selected from previously developed and validated instruments. The clinical investigators and research nurses reported on difficulty in using the HRQOL battery. Most patients were able to complete the questionnaire without problems within 10 min. Reproducibility was very good with intraclass correlation coefficients ranging from 0.74 to 0.97. The HRQOL scales showed evidence of good concurrent validity. The scales were moderately correlated with MADRS scores (r=0.30–0.62). The magnitude of these correlations indicate that HRQOL scales are related to depression measures, but they are not alternative measures of depression. Changes in MADRS scores were associated with changes in all scales, except for work behaviour, indicating that improvements in depression ratings also resulted in improvements in health status and well-being. The HRQOL scales included in this study were found to be reliable, reproducible, and valid and no appreciable burden was placed on patients or investigators participating in the study. With the exception of the Work Behaviour scale, the HRQOL scales were very responsive to changes in depression severity. This brief HRQOL instrument can provide a comprehensive assessment of the outcomes of antidepressant treatment.This research was supported by a grant from Pfizer International. 相似文献